Health Care · Electromedical & Electrotherapeutic Apparatus · OTC · CIK 839087 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $0.20Day +2.63%Mkt cap $34MP/E (FY) 19.5×1Y +62.5%Off 52W high −21.1%Vol (1Y) 70.5%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,412 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.0% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)+0.00% |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-08-15 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| P/E (FY)19.5× |
| Sales (TTM)$89.0M |
| Earnings (TTM)$1.8M |
| ROE5.5% |
| Net margin1.8% |
| EPS growth 3Y−45.0% |
| Sales growth 3Y4.0% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+14.7% |
| 1Y+62.5% |
| 3Y−31.6% |
| 5Y+235.6% |
| Since incept. (ann.)+35.5% |
Total return through 2026-07-30 · series begins 2020-06-02. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)70.5% |
| Ann. volatility (3Y)79.8% |
| Sharpe (1Y)1.03 |
| Sharpe (3Y)0.22 |
| Max drawdown (1Y)−25.0% |
| Max drawdown (3Y)−70.3% |
| Beta (3Y vs SPY)0.05 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| NBC SECURITIES, INC. | 5,000 | $849 | 0.00% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | −$0.01 | — | $19.4M | −0.5% |
| 2025-12-31 | 2026-03-31 | — | — | $27.0M | −0.1% |
| 2025-09-30 | 2025-11-14 | $0.01 | — | $22.7M | +9.1% |
| 2025-06-30 | 2025-08-14 | $0.00 | −100.0% | $20.0M | −1.3% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-15 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
Professional Sales Service Segments 33% · Professional Sales Services 33% · IT 31% · Equipment Segments 2% · Equipments 2%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.